Physician profile
John J Lee
NPI 1124237326
$12,786.24
in general payments reported to CMS, 2019-2025
20 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,670 · 2020: $94.55 · 2021: $8,118 · 2022: $319 · 2023: $786 · 2024: $352 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,585.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $8,164.84 | 2020-2022 | |
| Shire North American Group INC | $2,529.99 | 2019 | |
| Abbvie INC. | $459.94 | 2022-2025 | |
| Horizon Therapeutics Plc | $327.51 | 2022-2023 | Tepezza |
| Amgen INC. | $257.36 | 2024-2025 | Tepezza |
| Glaukos Corporation | $245.60 | 2023 | |
| Novartis Pharmaceuticals Corporation | $139.93 | 2021-2023 | |
| Alcon Vision LLC | $125.74 | 2019-2025 | Tryptyr, Eysuvis |
| Ani Pharmaceuticals, INC. | $117.06 | 2025 | Purified Cortrophin Gel |
| Tarsus Pharmaceuticals, INC. | $100.95 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $62.14 | 2022-2025 | Envista Envy Iol, Xiidra, Miebo |
| Dompe US, INC. | $56.69 | 2019-2024 | Oxervate |
| Alimera Sciences, INC. | $41.19 | 2019 | |
| Oyster Point Pharma, INC. | $28.23 | 2025 | Tyrvaya, Ryzumvi |
| Apellis Pharmaceuticals, INC. | $25.00 | 2024 | Syfovre |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $24.60 | 2021 | |
| Sight Sciences, INC. | $23.87 | 2019 | |
| Sun Pharmaceutical Industries INC. | $22.98 | 2023 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $18.42 | 2021 | |
| Esperion Therapeutics, INC. | $14.20 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.